|Positive WB detected in||mouse liver tissue|
|Positive IP detected in||mouse liver tissue|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Sample-dependent, check data in validation data gallery|
17165-1-AP targets ADH1B in WB, IP, IHC, IF, ELISA applications and shows reactivity with mouse, rat samples.
|Tested Reactivity||mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||ADH1B fusion protein Ag10630|
|Full Name||alcohol dehydrogenase 1B (class I), beta polypeptide|
|Calculated molecular weight||375 aa, 40 kDa|
|Observed molecular weight||40 kDa|
|GenBank accession number||BC033009|
|Gene ID (NCBI)||125|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
The ADH1B gene encodes the beta subunit of class I alcohol dehydrogenase (ADH), an enzyme that catalyzes the rate-limiting step for ethanol metabolism: the oxidation of alcohol to acetaldehyde. Class 1 ADH is a homo- or heterodimeric molecule, formed by the association of 3 types of class I ADH subunits, alpha (ADH1A), beta, and gamma(ADH1C). ADH1B is also named as ADH2 and belongs to the zinc-containing alcohol dehydrogenase family. This protein can exsit as a homodimer(PMID:19365573).
Cell Death Discov
Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer.
De novo-synthesized retinoic acid in ovarian antral follicles enhances FSH-mediated ovarian follicular cell differentiation and female fertility.
Arch Biochem Biophys
Baicalin ameliorates alcohol-induced hepatic steatosis by suppressing SREBP1c elicited PNPLA3 competitive binding to ATGL.
Exp Eye Res
Proteomic analysis reveals the heterogeneity of metabolic reprogramming in lacrimal gland tumors.
J Sci Food Agric
Probiotic-fermented Pueraria lobata (Willd.) Ohwi alleviates alcoholic liver injury by enhancing antioxidant defense and modulating gut microbiota
Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma